Immunohistochemical data from the HPA database, encompassing both lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), revealed significantly higher PLK1 expression in NSCLC patient tumor tissues compared to normal tissues (Supplementary Fig. 1C). Here, PLK1 is linked to non-small cell lung carcinoma.